Prevalence and phenomenology of olfactory hallucinations in Parkinson's disease

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 83, Issue 10, 2012, Pages 1019-1021

  Bannier, Stephanie ^a,b   Berdagué, Jean Louis ^c   Rieu, Isabelle ^a,b   De Chazeron, Ingrid ^a,b   Marques, Ana ^a,b   Derost, Philippe ^a,b   Ulla, Miguel ^a,b   Llorca, Pierre Michel ^a,b   Durif, Franck ^a,b  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c CEMAGREF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OLFACTORY DISCRIMINATION; OLFACTORY HALLUCINATION; PARKINSON DISEASE; PHENOMENOLOGY; PRIORITY JOURNAL;

EID: 84866156998     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2012-302414     Document Type: Article

References (15)

1. Fenelon G, Mahieux F, Huon R, et al. Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. Brain 2000;123:733-45. (Pubitemid 30162723)
2. Tousi B, Frankel M. Olfactory and visual hallucinations in Parkinson's disease. Parkinsonism Relat Disord 2004;10:253-4. (Pubitemid 38534620)
3. Doty RL, Stern MB, Pfeiffer C, et al. Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1992;55:138-42.
4. Cambou S. Identification des composes aromatiques clés impliqués dans les comportement d'attrait ou de rejet d'un produit laitier par les consommateurs. doctorat d'université: université d'Auvergne, 2007.
5. Doty RL, Bromley SM, Stern MB. Olfactory testing as an aid in the diagnosis of Parkinson's disease: development of optimal discrimination criteria. Neurodegeneration 1995;4:93-7.
6. Papapetropoulos S, Katzen H, Schrag A, et al. A questionnaire-based (UM-PDHQ) study of hallucinations in Parkinson's disease. BMC Neurol 2008;8:21.
7. Goetz CG, Wuu J, Curgian L, et al. Age-related influences on the clinical characteristics of new-onset hallucinations in Parkinson's disease patients. Mov Disord 2006;21:267-70.
8. Stevenson RJ, Langdon R, McGuire J. Olfactory hallucinations in schizophrenia and schizoaffective disorder: a phenomenological survey. Psychiatry Res 2010;185:321-7.
9. Elliott B, Joyce E, Shorvon S. Delusions, illusions and hallucinations in epilepsy: 1. Elementary phenomena. Epilepsy Res 2009;85:162-71.
10. Onofrj M, Bonanni L, Albani G, et al. Visual hallucinations in Parkinson's disease: clues to separate origins. J Neurol Sci 2006;248:143-50. (Pubitemid 44754867)
11. Shine JM, Halliday GM, Naismith SL, et al. Visual misperceptions and hallucinations in Parkinson's disease: dysfunction of attentional control networks? Mov Disord 2011;26:2154-9.
12. Stephenson R, Houghton D, Sundarararjan S, et al. Odor identification deficits are associated with increased risk of neuropsychiatric complications in patients with Parkinson's disease. Mov Disord 2010;25:2099-104.
13. Braak H, Del Tredici K, Rub U, et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197-211. (Pubitemid 36007810)
14. Holroyd S, Currie L, Wooten GF. Prospective study of hallucinations and delusions in Parkinson's disease. J Neurol Neurosurg Psychiatry 2001;70:734-8. (Pubitemid 32554202)
15. Rouby C, Thomas-Danguin T, Vigouroux M, et al. The lyon clinical olfactory test: validation and measurement of hyposmia and anosmia in healthy and diseased populations. Int J Otolaryngol 2011;2011:203805.